On February 9, 2026, AK Medical Holdings Limited issued a voluntary announcement disclosing the Group’s latest business developments in orthopedic surgical robotics and digital orthopedics. The announcement was made voluntarily by the Company (together with its subsidiaries, collectively referred to as the “Group”) to provide shareholders and potential investors with updated information regarding its recent business progress.

K3 Orthopedic Robotic System: Fully Proprietary Robotic Arm Supporting Preoperative Planning and Intraoperative Assistance

The announcement also disclosed AK Medical’s latest progress in orthopedic surgical robotics. The K3 Surgical Robotic System (the “K3 Robotic System”) features a fully proprietary robotic arm independently developed by the Group. The system is compact and elegantly designed, requiring no additional operating room space.

During surgery, the K3 Robotic System operates with stability and efficiency, providing functions ranging from preoperative planning to intraoperative assistance in bone resection and joint stability prediction. It aims to help restore knee joint function while improving surgical precision and efficiency. Its unique design enables surgeons to complete osteotomy procedures with greater ease, further enhancing surgical workflow and safety.

According to the announcement, on January 15, 2026, the K3+ Robotic System received market approval from China’s National Medical Products Administration (NMPA).

The K3+ Robotic System is the first domestically developed total joint surgical robot capable of performing revision surgeries. It covers indications including hip, knee, and unicompartmental procedures, marking a further expansion and refinement of AK Medical’s joint surgical robotics portfolio.

VTS Visual Treatment Solution: Advancing Intelligent Visual-Assisted Surgery

AK Medical also disclosed details of its Visual Treatment Solution (VTS) System, an intelligent visual-assisted surgical platform.

The VTS System leverages medical-engineering interaction to support preoperative planning and real-time intraoperative visualization, aiming to enhance surgical performance and clinical outcomes in total hip arthroplasty (THA).

The system integrates 3D printing-based digital manufacturing technology with intelligent visual assistance, adapting to the complex environment of hip replacement procedures. From preoperative CT data processing and 3D surgical planning to intraoperative real-time visual tracking and acetabular implant placement, the VTS System provides full-process support throughout the surgical workflow.

MedChina Observation

Based on the information disclosed in this announcement, AK Medical appears to be advancing both joint surgical robotics and digital orthopedics in parallel.

On one hand, the approval of the K3+ Robotic System—now capable of covering revision surgeries—signals that domestically developed joint surgical robots in China are beginning to expand toward more technically complex procedures, moving beyond primary replacement scenarios and aiming to enter higher-value hospital application segments.

On the other hand, procurement wins and collaborations with multiple tertiary (Class III) and provincial key hospitals indicate that these products are gradually entering real-world clinical environments.

Overall, this disclosure reflects a phased milestone in AK Medical’s simultaneous advancement of robotic platform capabilities and complementary digital service ecosystems. However, the long-term impact and commercial success of these developments will ultimately depend on the depth of clinical adoption and sustained implementation in practice.

February 20, 2026, MedChina